Henry C
Make sure to consult with an expert professional provider, and tailor the approach to your unique needs.
Regulatory & Legal Status AOD-9604 has no FDA-approved therapeutic use and has never been cleared for human consumption by any government health authority worldwide it exists in a pre-clinical/discontinued-development status, which is the basis for its banned classification
For signs of infection at the injection site (rapidly spreading redness, warmth, swelling, or pus) or systemic symptoms such as high fever, chills, or feeling severely unwell, contact NHS 111 or attend an urgent treatment centre promptly
The team focused on CUDC-907, a dual inhibitor that combines PI3K and HDAC blockade
The correct dosage varies depending on whether you are maintaining adequate levels or treating a deficiency